Internal Medicine, Infectious Disease · Greeley, CO
NPI
1932180551
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6767 29th St Fl 2
Greeley, CO, 80634
Phone (970) 237-7588
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
921 services
Medicare patients, 2024
366
Average age 74
Drug cost, 2024
$641K
999 prescriptions
Company payments, 2024
$28.5
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel H Monkowski was code 99232 (hospital e&m - subsequent), 466 times for 216 patients. In total Daniel H Monkowski billed 921 services in 15 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 466 | 216 | $60.71 | $28K |
| 99213 Office E&M - Established | Office | 268 | 132 | $67.45 | $18K |
| 99222 Hospital E&M - Initial | Facility | 104 | 98 | $99.37 | $10K |
| 99183 Hyperbaric Oxygen | Facility | 31 | 11 | $79.84 | $2,475 |
| 99203 Office E&M - New | Office | 15 | 15 | $89.05 | $1,336 |
By year: 2022 $98K for 1,408 services; 2023 $60K for 856 services; 2024 $62K for 921 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel H Monkowski prescribed most often to Medicare patients was Cefadroxil, with 126 prescriptions and refills. In total Daniel H Monkowski wrote 999 Medicare prescriptions that cost $641K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cefadroxil Generic | 126 | 213 | 22 | $6,486 |
| Cephalexin Generic | 75 | 120 | 27 | $4,241 |
| Doxycycline Monohydrate Generic | 55 | 117 | 23 | $5,436 |
| Vancomycin Hcl Generic | 54 | 64 | 13 | $15K |
| Ertapenem Ertapenem Sodium | 48 | 48 | Under 11 | $18K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 70 | 14 | $777 |
| Amoxicillin Generic | 44 | 94 | 18 | $822 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 65 | 21 | $1,483 |
| Fluconazole Generic | 36 | 64 | 13 | $2,064 |
| Daptomycin Generic | 34 | 34 | Under 11 | $28K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 30 | 40 | Under 11 | $174K |
| Cefazolin Sodium Generic | 28 | 28 | Under 11 | $2,298 |
| Doxycycline Hyclate Generic | 27 | 65 | Under 11 | $1,858 |
| Darunavir Generic | 25 | 25 | Under 11 | $10K |
| Isentress Raltegravir Potassium | 24 | 24 | Under 11 | $51K |
Brand drugs: 131 claims; generic drugs: 868 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Daniel H Monkowski $28.5 ($28.5 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $28.5.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $28.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.